<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art18">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73678</ArticleID>
            <ArticleDOI>10.1208/aapsj070368</ArticleDOI>
            <ArticleSequenceNumber>18</ArticleSequenceNumber>
            <ArticleTitle Language="En">Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the α4β2 nicotinic acetylcholine receptor subtype using nonlinear techniques</ArticleTitle>
            <ArticleFirstPage>E678</ArticleFirstPage>
            <ArticleLastPage>E685</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>3</Month>
                <Day>7</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>30</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" PresentAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joshua</GivenName>
                  <GivenName>T.</GivenName>
                  <FamilyName>Ayers</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Aaron</GivenName>
                  <FamilyName>Clauset</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeffrey</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Schmitt</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Linda</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Dwoskin</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Peter</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Crooks</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(859) 257-1718</Phone>
                  <Fax>(859) 257-1718</Fax>
                  <Email>pcrooks@email.uky.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>College of Pharmacy</OrgDivision>
                <OrgName>University of Kentucky</OrgName>
                <OrgAddress>
                  <Postcode>40536-0082</Postcode>
                  <City>Lexington</City>
                  <State>KY</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgName>AstraZeneca Pharmaceuticals LP</OrgName>
                <OrgAddress>
                  <Street>1800 Concord Pike</Street>
                  <Postcode>19850-5437</Postcode>
                  <City>Wilmington</City>
                  <State>DE</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgDivision>Department of Computer Science</OrgDivision>
                <OrgName>University of New Mexico</OrgName>
                <OrgAddress>
                  <Postcode>87131</Postcode>
                  <City>Albuquerque</City>
                  <State>NM</State>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff4">
                <OrgName>Targacept Inc</OrgName>
                <OrgAddress>
                  <Street>200 East First Street</Street>
                  <Postcode>27101-4165</Postcode>
                  <City>Winston-Salem</City>
                  <State>NC</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>The neuronal nicotinic acetylcholine receptor (nAChR) has been a target for drug development studies for over a decade. A series of<Emphasis Type="Italic">mono</Emphasis>- and<Emphasis Type="Italic">bis</Emphasis>-quaternary ammonium salts, known to be antagonists at nAChRs, were separated into 3 structural classes and evaluated using both self-organizing map (SOM) and genetic functional approximation (GFA) algorithm models. Descriptors from these compounds were used to create several nonlinear quantitative structure-activity relationships (QSARs). The SOM methodology was effective in appropriately grouping these compounds with diverse structures and activities. The GFA models were also able to predict the activities of these molecules. Charge distribution and the hydrophobic free energies were found to be important indicators of bioactivity for this particular class of molecules. These QSAR approaches may be a useful to screen and select<Emphasis Type="Italic">in silico</Emphasis> new drug candidates from larger compound libraries to be further evaluated in in vitro biological assays.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>self-organizing map</Keyword>
              <Keyword>genetic functional approximation</Keyword>
              <Keyword>neuronal nicotinic acetylcholine receptor</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 25, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73678.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Lindstrom</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Nicotinic acetylcholine receptors in health and disease</ArticleTitle>
                  <JournalTitle>Mol Neurobiol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>193</FirstPage>
                  <LastPage>222</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9396010</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF02740634</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXotVCku7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lindstrom J. Nicotinic acetylcholine receptors in health and disease.<Emphasis Type="Italic">Mol Neurobiol</Emphasis>. 1997;15:193–222.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Dani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Biasi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Liang</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Potential applications of nicotinic ligands in the laboratory and clinic</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>1837</FirstPage>
                  <LastPage>1839</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15050611</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmcl.2003.07.036</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXislSqtLY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dani JA, Biasi M, Liang Y, et al. Potential applications of nicotinic ligands in the laboratory and clinic.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2004;14:1837–1839.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GK</Initials>
                    <FamilyName>Lloyd</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic acetylcholine receptors as novel drug targets</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>292</VolumeID>
                  <FirstPage>461</FirstPage>
                  <LastPage>467</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10640281</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotFegsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lloyd GK, Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2000;292:461–467.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RC</Initials>
                    <FamilyName>Hogg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bertrand</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Nicotinic acetylcholine receptors as drug targets</ArticleTitle>
                  <JournalTitle>Curr Drug Target CNS Neurol Disord</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>123</FirstPage>
                  <LastPage>130</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1568007043482507</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXisFWksrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hogg RC, Bertrand D. Nicotinic acetylcholine receptors as drug targets.<Emphasis Type="Italic">Curr Drug Target CNS Neurol Disord</Emphasis>. 2004;3:123–130.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Recent developments in neuronal nicotinic acetylcholine receptor antagonists</ArticleTitle>
                  <JournalTitle>Curr Opin Ther Patents</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>1561</FirstPage>
                  <LastPage>1581</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/13543776.10.10.1561</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXnt1antrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Xu R, Ayers JT, Crooks PA. Recent developments in neuronal nicotinic acetylcholine receptor antagonists.<Emphasis Type="Italic">Curr Opin Ther Patents</Emphasis>. 2000;10:1561–1581.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>395</FirstPage>
                  <LastPage>402</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11454899</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlsVKqsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dwoskin LP, Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:395–402.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Nicolotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pellegrini-Calace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Carrieri</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore</ArticleTitle>
                  <JournalTitle>J Comput Aided Mol Des</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>859</FirstPage>
                  <LastPage>872</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11776295</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1013115717587</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XovFGq</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nicolotti O, Pellegrini-Calace M, Carrieri A, et al. Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2001;15:859–872.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SF</Initials>
                    <FamilyName>Nielsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EO</Initials>
                    <FamilyName>Nielsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Olsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Liljefors</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Peters</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>2217</FirstPage>
                  <LastPage>2226</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10841800</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm990973d</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXivFens7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nielsen SF, Nielsen EO, Olsen GM, Liljefors T, Peters D. Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2000; 43:2217–2226.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dukat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Fiedler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Dumas</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Pyrrolidine-modified and 6-substituted analogs of nicotine: a structure-affinity investigation</ArticleTitle>
                  <JournalTitle>Eur J Med Chem</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>875</FirstPage>
                  <LastPage>888</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0223-5234(97)89850-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XntlKlsL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dukat M, Fiedler W, Dumas D, et al. Pyrrolidine-modified and 6-substituted analogs of nicotine: a structure-affinity investigation.<Emphasis Type="Italic">Eur J Med Chem</Emphasis>. 1996;31:875–888.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Barlow</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>McLeod</FamilyName>
                  </BibAuthorName>
                  <Year>1969</Year>
                  <ArticleTitle Language="En">Some studies on cytisine and its methylated derivatives</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>161</FirstPage>
                  <LastPage>174</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4387392</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaF1MXls1SlsQ%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1476-5381.1969.tb07977.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Barlow RB, McLeod LJ. Some studies on cytisine and its methylated derivatives.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1969;35:161–174.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Barlow</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds</ArticleTitle>
                  <JournalTitle>Br J Pharmacol</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>799</FirstPage>
                  <LastPage>808</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2590771</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXhvFc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Barlow RB, Johnson O. Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1989;98:799–808.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Tonder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PH</Initials>
                    <FamilyName>Olesen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Begtrup</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Pettersson</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labeled by [<Superscript>3</Superscript>H]-N-methylcarbamylcholine</ArticleTitle>
                  <JournalTitle>J Comput Aided Mol Des</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>247</FirstPage>
                  <LastPage>258</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11289078</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1023/A:1008140021426</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitlWjtLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tonder JE, Olesen PH, Hansen JB, Begtrup M, Pettersson I. An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labeled by [<Superscript>3</Superscript>H]-N-methylcarbamylcholine.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2001;15:247–258.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Tonder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PH</Initials>
                    <FamilyName>Olesen</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modeling</ArticleTitle>
                  <JournalTitle>Curr Med Chem</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>651</FirstPage>
                  <LastPage>674</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11281847</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXivVClt7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tonder JE, Olesen PH. Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modeling.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2001;8:651–674.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Schmitt</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Exploring the nature of molecular recognition in nicotinic acetylcholine receptors</ArticleTitle>
                  <JournalTitle>Curr Med Chem</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>749</FirstPage>
                  <LastPage>800</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10828287</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXltVGitLg%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.2174/0929867003374660</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Schmitt JD. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2000;7:749–800.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Sheridan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Nilakantan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JS</Initials>
                    <FamilyName>Dixon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Venkataraghavan</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">The ensemble approach to distance geometry: application to the nicotinic pharmacophore</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>899</FirstPage>
                  <LastPage>906</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3712379</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00156a005</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XitVOmsrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sheridan RP, Nilakantan R, Dixon JS, Venkataraghavan R. The ensemble approach to distance geometry: application to the nicotinic pharmacophore.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1986;29:899–906.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Glennon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Dukat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Liao</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models</ArticleTitle>
                  <JournalTitle>Curr Top Med Chem</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>631</FirstPage>
                  <LastPage>644</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14965299</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1568026043451122</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjtVeis70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Glennon RA, Dukat M, Liao L. Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.<Emphasis Type="Italic">Curr Top Med Chem</Emphasis>. 2004;4:631–644.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Brejc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WJ</Initials>
                    <FamilyName>Dijk</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Klaassen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Crystal structure of AChBP reveals the ligand-binding domain of nicotinic receptors</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>411</VolumeID>
                  <FirstPage>269</FirstPage>
                  <LastPage>276</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11357122</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/35077011</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjvF2qsbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brejc K, van Dijk WJ, Klaassen R, et al. Crystal structure of AChBP reveals the ligand-binding domain of nicotinic receptors.<Emphasis Type="Italic">Nature</Emphasis>. 2001;411:269–276.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zupan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Gasteiger</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <BookTitle>Neuronal Networks for Chemists</BookTitle>
                  <PublisherName>VCH</PublisherName>
                  <PublisherLocation>New York, NY</PublisherLocation>
                </BibBook>
                <BibUnstructured>Zupan J, Gasteiger J.<Emphasis Type="Italic">Neuronal Networks for Chemists</Emphasis>. New York, NY: VCH; 1993.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kohonen</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <BookTitle>Self-organizing Maps</BookTitle>
                  <PublisherName>Springer</PublisherName>
                  <PublisherLocation>Berlin, Germany</PublisherLocation>
<Occurrence Type="DOI">
<Handle>10.1007/978-3-642-56927-2</Handle>
</Occurrence>
                </BibBook>
                <BibUnstructured>Kohonen T.<Emphasis Type="Italic">Self-organizing Maps</Emphasis>, Berlin, Germany: Springer, 2001.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Rogers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Hopfinger</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships</ArticleTitle>
                  <JournalTitle>J Chem Inf Comput Sci</JournalTitle>
                  <VolumeID>34</VolumeID>
                  <FirstPage>854</FirstPage>
                  <LastPage>866</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ci00020a020</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXkslejt7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rogers D, Hopfinger AJ. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships.<Emphasis Type="Italic">J Chem Inf Comput Sci</Emphasis> 1994;34:854–866.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Korff</FamilyName>
                    <Particle>von</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Steger</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">GPCR-tailored pharmacophore pattern recognition of small molecular ligands</ArticleTitle>
                  <JournalTitle>J Chem Info &amp; Comp Sci</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>1137</FirstPage>
                  <LastPage>1147</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ci0303013</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>von Korff M, Steger M. GPCR-tailored pharmacophore pattern recognition of small molecular ligands.<Emphasis Type="Italic">J Chem Info &amp; Comp Sci</Emphasis>. 2004;44:1137–1147.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Schneider</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nettekoven</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps</ArticleTitle>
                  <JournalTitle>J Comb Chem</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <FirstPage>233</FirstPage>
                  <LastPage>237</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12739938</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/cc020092j</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhsFWjt74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schneider G, Nettekoven M. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.<Emphasis Type="Italic">J Comb Chem</Emphasis>. 2003;5:233–237.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>So</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Helden</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Geerestein</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Karplus</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Quantitative structure-activity relationship studies of progesterone receptor binding steroids</ArticleTitle>
                  <JournalTitle>J Chem Info &amp; Comp Sci</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>762</FirstPage>
                  <LastPage>772</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXivVWhs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>So S, van Helden S, van Geerestein V, Karplus M. Quantitative structure-activity relationship studies of progesterone receptor binding steroids.<Emphasis Type="Italic">J Chem Info &amp; Comp Sci</Emphasis>. 2000;40:762–772.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Yuan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Parrill</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">QSAR studies of HIV-1 integrase inhibition</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>4169</FirstPage>
                  <LastPage>4183</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12413870</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0968-0896(02)00332-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xot1ens78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yuan H, Parrill A. QSAR studies of HIV-1 integrase inhibition.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2002;10:4169–4183.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Gokhale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Kulkarni</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Understanding the antifungal activity of terbinafine analogues using structure-activity relationship (QSAR) models</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <FirstPage>2487</FirstPage>
                  <LastPage>2499</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11058044</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0968-0896(00)00178-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmsFylu7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gokhale V, Kulkarni V. Understanding the antifungal activity of terbinafine analogues using structure-activity relationship (QSAR) models.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2000;8:2487–2499.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>400</FirstPage>
                  <LastPage>410</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12490617</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.043349</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXht1SntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wilkins LHJr, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.<Emphasis Type="Italic">N-n</Emphasis>-Alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> neuronal nicotinic receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:400–410.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Deaciuc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>1245</FirstPage>
                  <LastPage>1248</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11354387</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(01)00193-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjt1Witbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Xu R, Dwoskin LP, Grinevich VP, Deaciuc G, Crooks PA. Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2001;11:1245–1248.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Deaciuc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">
                    <Emphasis Type="Italic">bis</Emphasis>-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> subtypes of neuronal nicotinic receptors</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>3067</FirstPage>
                  <LastPage>3071</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12372503</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(02)00687-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xns1Ohur8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA.<Emphasis Type="Italic">bis</Emphasis>-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2<Superscript>*</Superscript> and alpha7<Superscript>*</Superscript> subtypes of neuronal nicotinic receptors.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2002;12:3067–3071.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VP</Initials>
                    <FamilyName>Grinevich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Sumithran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Haubner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ayers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">N-n-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H]dopamine overflow from superfused rat striatal</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>306</VolumeID>
                  <FirstPage>1011</FirstPage>
                  <LastPage>1020</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12766255</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.051789</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvVeht70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Grinevich VP, Crooks PA, Sumithran P, Haubner AJ, Ayers JT, Dwoskin LP. N-n-Alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H]dopamine overflow from superfused rat striatal.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:1011–1020.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Bayram</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Santago</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y-D</Initials>
                    <FamilyName>Xiao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Clauset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Schmitt</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Genetic algorithms and self-organizing maps: a powerful combination for modeling complex QSAR and QSPR problems</ArticleTitle>
                  <JournalTitle>J Comput Aided Mol Des</JournalTitle>
                  <VolumeID>187–9</VolumeID>
                  <FirstPage>483</FirstPage>
                  <LastPage>493</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s10822-004-5321-2</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bayram E, Santago P, Harris R, Xiao Y-D, Clauset AJ, Schmitt JD. Genetic algorithms and self-organizing maps: a powerful combination for modeling complex QSAR and QSPR problems.<Emphasis Type="Italic">J Comput Aided Mol Des</Emphasis>. 2004;187–9:483–493.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Crooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ravard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Wilkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Teng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ST</Initials>
                    <FamilyName>Buxton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LP</Initials>
                    <FamilyName>Dwoskin</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Inhibition of nicotine-evoked [3H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist</ArticleTitle>
                  <JournalTitle>Drug Dev Res</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>102</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ddr.430360204</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXptVyms7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Crooks PA, Ravard A, Wilkins LH, Teng L, Buxton ST, Dwoskin LP. Inhibition of nicotine-evoked [3H]dopamine release by pyridino<Emphasis Type="Italic">N</Emphasis>-substituted nicotine analogues: a new class of nicotinic antagonist.<Emphasis Type="Italic">Drug Dev Res</Emphasis>. 1995;36:91–102.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
